Under construction – not a live service
Sign in
Taking people in PakistanNo phase

Neurocognitive therapy with or without a soft robotic hand for hand recovery after stroke

Compares neurocognitive therapy, with and without a robotic glove, in people recovering from stroke.

Plain-language title generated from the registry record
Registry title: Effects Of Neurocognitive Therapy With And Without Soft Robotic Hand On Hand Function

Key facts

Where
Lahore, PakistanSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 40 and 60 years old?

Source: NCT06927284, who can take part

Where in Pakistan

  • Sheikh Zayad HospitalLahore, PakistanTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Riphah International University
Trial code
NCT06927284
Record updated
22 August 2025
Original description
To determine the effect of neurocognitive therapy with and without a soft robotic hand on manual ability, dexterity, strength, spasticity and upper limb function in sub-acute stroke.Read full original descriptionShow less

Effects of Neurocognitive Therapy With and Without Soft Robotic Hand on Hand Function in Sub-acute Stroke

To determine the effect of neurocognitive therapy with and without a soft robotic hand on manual ability, dexterity, strength, spasticity and upper limb function in sub-acute stroke.

Inclusion: Participants of Post stroke patients (6-12 weeks ); Participants with Spasticity < 2 on modified Ashworth scale; Participants with first ever stroke; Participants with normal cognition > 24 on MoCA; Participants must be able to provide informed consent; Hemiparesis with arm motor deficit as assessed by with NIHSS >1(14).

Exclusion: Participants who have active pacemakers and other active implants; Participants who have a history of significant neurological or orthopedic disorders, other than stroke, that could interfere with upper limb motor or sensory recovery; Participants who have altered state of consciousness, severe aphasia, severe cognitive deficit; Participants who have severe pathologies of traumatic and or rheumatic nature, severe pain in effected arm (>5 on visual analog scale for pain) .

ClinicalTrials.gov NCT06927284